Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 27 Jun 2007):

Dopaminergic potentiation of rTMS-induced motor cortex inhibition.

Full Abstract

BACKGROUND: Experiments in animal models suggest that neuronal plasticity can be enhanced by dopaminergic receptor activation. The present study tested whether stimulation-induced plasticity of human motor cortex after low-frequency repetitive transcranial magnetic stimulation (rTMS) could be potentiated by a single oral dose of the combined D1/D2 receptor agonist pergolide. METHODS: In a randomized, double-blind, placebo-controlled cross-over design, nine healthy young volunteers received .125 mg pergolide or placebo 2 hours before 1 Hz rTMS was applied for 20 min to the left primary motor cortex. In a control experiment 7 subjects received .125 mg pergolide 2 hours before sham rTMS. We used single-pulse TMS at rest to assess corticospinal excitability before and up to 24 min after rTMS. RESULTS: Suppression of corticospinal excitability by 1 Hz rTMS was more pronounced after pergolide intake compared with placebo and lasted approximately 20 min after pergolide but only 5 min after placebo. No change of corticospinal excitability could be observed when sham rTMS was performed after pergolide intake. CONCLUSIONS: The results suggest a possible role for dopaminergic potentiation of rTMS-induced neuroplasticity in experimental or therapeutic applications and should be considered when rTMS is applied in patients under medication with dopamine agonists or antagonists.

 

Author information

Author/s: Lang, Nicolas (N); Speck, Sascha (S); Harms, Jochen (J); Rothkegel, Holger (H); Paulus, Walter (W); Sommer, Martin (M);

Affiliation: Department of Neurology, Christian-Albrechts University, Kiel, Germany. nlang(-atsign-)gwdg.de

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal: Biological psychiatry (Biol Psychiatry), published in United States. (Language: eng)

Reference: 2008-Jan; vol 63 (issue 2) : pp 231-3

Dates: Created 2007/12/31; Completed 2008/02/27; Revised 2008/04/02;

PMID: 17604004, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Dopamine Agonists (0) ; Dopamine (51-61-6) ; Pergolide (66104-22-1)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

5/30/1999
4/29/2008
Higher Relevance Score (46)
Lower Relevance Score (32)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index